Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Imiquimod 5% Topical Cream
DRUG
2 trials
Sponsors
Xiangya Hospital of Central South University
, University of Michigan
Conditions
Melanoma (Skin)
Sebaceous Hyperplasia
Phase 1
A Personalized NeoAntigen Cancer Vaccine Combined With Anti-PD-1 in Melanoma
NCT04072900
Xiangya Hospital of Central South University
Melanoma (Skin)
Start: 2020-04-21
End: 2022-09-01
Target: 30
Updated: 2020-04-28
Phase 4
Investigating the Effect of Topical Imiquimod on Sebaceous Hyperplasia
Active, not recruiting
NCT06840470
University of Michigan
Sebaceous Hyperplasia
Start: 2025-03-11
End: 2026-05-31
Target: 40
Updated: 2026-05-07